lisuride has been researched along with Idiopathic Parkinson Disease in 157 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 92 (58.60) | 18.7374 |
1990's | 44 (28.03) | 18.2507 |
2000's | 19 (12.10) | 29.6817 |
2010's | 1 (0.64) | 24.3611 |
2020's | 1 (0.64) | 2.80 |
Authors | Studies |
---|---|
Gupta, SK; Kumar, S; Pahwa, R | 1 |
Agúndez, JA; Alonso-Navarro, H; García-Martín, E; Jiménez-Jiménez, FJ | 1 |
Stocchi, F | 1 |
Olanow, CW; Ruggieri, S; Stocchi, F; Vacca, L | 1 |
Gekht, AB | 1 |
Benz, S; Horowski, R; Müller, T; Przuntek, H; Woitalla, D | 1 |
Gerlach, M; Reichmann, H; Riederer, P | 1 |
Goetz, CG; Poewe, W; Rascol, O; Sampaio, C | 1 |
Feenstra, RW; Glennon, JC; Hesselink, MB; Long, SK; McCreary, AC; Reinders, JH; Ronken, E; Van Der Neut, M; Van Scharrenburg, G | 1 |
Görnemann, T; Pertz, HH; Schurad, B; Seifert, R; Strasser, A | 1 |
Burton, K; Calne, DB | 1 |
Lees, AJ; Stern, GM | 1 |
Kurako, IuL; Volianskiĭ, VE | 1 |
Beckman, J; Burton, K; Calne, DB; Martin, WR | 1 |
Agnoli, A; Bedini, L; Casacchia, M; Castellana, F; Cusimano, G; Meco, G | 1 |
Goldstein, M; Gopinathan, G; Hiesiger, E; Leibowitz, M; Lieberman, AN; Neophytides, A; Walker, R | 1 |
Burns, RS; Calne, DB; LeWitt, PA | 1 |
Birkmayer, W; Danielczyk, W; Jellinger, K; Koppel, H; Reynolds, GP; Riederer, P; Seemann, D; Ulm, G | 1 |
von Werder, K | 1 |
Da Prada, M; Haefely, WE; Keller, HH; Kettler, R; Pieri, L | 1 |
Bolio, N; Luquin, MR; Martinez-Lage, JM; Obeso, JA | 1 |
Goldstein, M; Gopinathan, G; Leibowitz, M; Lieberman, AN; Neophytides, A | 1 |
Horowski, R; Suchy, I | 1 |
Caraceni, T; Carella, F; Giovannini, P; Grassi, MP; Parati, E; Scigliano, G | 2 |
Bassi, S; Bosio, A; Covelli, V; Frattola, L; Govoni, S; Spano, PF; Trabucchi, M | 1 |
Burns, RS; Calne, DB; Dorow, R; Gopinathan, G; Hümpel, M | 1 |
Gopinathan, G; Hiesiger, E; Leibowitz, M; Lieberman, AN; Neophytides, A; Walker, R | 1 |
Agostini, L; Piccinin, GL; Piccirilli, M; Rizzo, PA | 1 |
Brincat, S; Lang, AE; Marsden, CD; Parkes, D; Quinn, NP; Sheehy, MP | 1 |
Horowski, R; McDonald, RJ | 1 |
Goldstein, M; Goodgold, A; Gopinathan, G; Leibowitz, M; Lieberman, AN; Neophytides, A; Pact, V; Walker, R | 1 |
Calne, DB; Teräväinen, H | 1 |
Goldstein, M; Kleinberg, D; Kupersmith, M; Leibowitz, M; Lieberman, A; Neophytides, A; Walker, R; Zasorin, N | 1 |
Goldstein, M; Gopinathan, G; Leibowitz, M; Lieberman, AN; Neophytides, A; Pact, V; Walker, R | 1 |
Calne, DB; Dambrosia, JM; Durso, R; Gopinathan, G; LeWitt, PA; Sanes, JN; Ward, CD | 1 |
Bock, J; Goldstein, M; Gopinathan, G; Leibowitz, M; Lieberman, AN; Neophytides, A; Walker, R | 1 |
Calne, DB; Dambrosia, JM; Evarts, EV; Gopinathan, G; Sanes, JN; Stuart, WK; Teräväinen, H; Ward, CD | 1 |
Marsden, CD; Parkes, JD; Schachter, M; Smith, B; Wilson, A | 1 |
González, ER | 1 |
Caraceni, T; Giovannini, P; Martinez-Campos, A; Müller, EE; Novelli, A; Parati, E | 1 |
Bédard, P; Debono, AG; Dorow, R; Horowski, R; Jenner, P; Keenan, J; Marsden, CD; Parkes, JD; Price, P; Rosenthaler, J; Schachter, M; Smith, B | 1 |
Marsden, CD; Parkes, JD; Schachter, M; Sheehy, MP | 1 |
Heinz, A; Pietzcker, A; Przuntek, H; Winterer, G | 1 |
Cordes, M; Eichstädt, H; Felix, R; Hierholzer, J; Poewe, W; Richter, W; Schelosky, L; Schrag, A; Schulze, PE; Semmler, W | 1 |
Akai, T; Kuno, S; Mizuta, E; Ozawa, M; Yamaguchi, M | 1 |
Guilarte, TR; May, CH; Vogel, S; Wagner, HN | 1 |
Brown, D; Factor, SA; Molho, ES; Podskalny, GD | 1 |
Aufdembrinke, B; Bruggi, P; Godi, L; Martignoni, E; Miltenburger, C; Nappi, G; Pacchetti, C; Voet, B | 1 |
Antonini, A; Beer, HF; Leenders, KL; Madeja, UD; Oertel, WH; Schwarz, J | 1 |
Ferrarese, C; Piolti, R; Pozzi, C | 1 |
Baier, JE; Gallati, H; Kovacs, S; Neumann, HA; Poehlau, D; Przuntek, H; Schmutz, T; Suchy, I; Will, C | 1 |
Klockgether, T; Löschmann, PA; Schugens, MM | 1 |
Baronti, F; Bramante, L; Monge, A; Ruggieri, S; Stefano, E; Stocchi, F; Viselli, F | 1 |
Koivikko, L; Portin, R; Revonsuo, A; Rinne, JO; Rinne, UK | 1 |
Cordes, M; Eichstädt, H; Felix, R; Hierholzer, J; Poewe, W; Richter, WS; Schelosky, L; Schrag, A; Schulze, PE | 1 |
Bayülkem, B; Bayülkem, K; Erişir, K; Tuncel, A | 1 |
Attanasio, R; Costa, A; Cozzi, R; Dallabonzana, D; Horowski, R; Liuzzi, A; Martignoni, E; Nappi, G; Rainer, E | 1 |
Fuchs, G | 1 |
Barbato, L; Berardelli, A; Bonamartini, A; Manfredi, M; Patsalos, PN; Ruggieri, S; Stocchi, F | 1 |
Eising, EG; Jacob, M; Kuhn, W; Müller, T; Przuntek, H; Reiners, C | 1 |
Hayashi, R; Koyama, J; Makishita, H; Tako, K; Yanagisawa, N | 1 |
Fukuda, T; Irifune, M; Iwata, S; Kaseda, S; Nomoto, M; Osame, M | 1 |
Bardin, PG; Battistin, L; Ferro-Milone, F; Ravenna, C; Reboldi, G; Toso, V | 1 |
Autret, A; Baulieu, JL; Besnard, JC; Chartier, JR; Cottier, JP; Guilloteau, D; Levilion-Prunier, C; Pourcelot, L; Ribeiro, MJ; Tranquart, F | 1 |
Montastruc, JL; Rascol, O; Senard, JM | 1 |
Ferreira, JJ; Galitzky, M; Montastruc, JL; Rascol, O | 1 |
Clarke, CE; Speller, JM | 2 |
Allain, H; Bentué-Ferrer, D; Destée, A; Le Cavorzin, P; Patay, M; Petit, H; Schück, S | 1 |
Berardelli, A; De Pandis, F; Ruggieri, S; Stocchi, F; Vacca, L | 1 |
Diroma, C; Fraddosio, A; Iliceto, G; Lamberti, S; Moramarco, A; Palagano, G; Zenzola, A | 1 |
Autret, A; Baulieu, JL; Besnard, JC; Chalon, S; Chossat, F; Cottier, JP; De Toffol, B; Giraudeau, B; Guilloteau, D; Prunier, C; Tranquart, F | 1 |
Schrag, A; Trimble, M | 1 |
Blackstock, J; Dick, JP; George, RJ; Marsden, CD; Parkes, JD; Schachter, M | 1 |
Goldstein, M; Kleinberg, D; Kupersmith, M; Leibowitz, M; Lieberman, AN; Mehl, S; Neophytides, A; Serby, M | 1 |
Diederich, NJ; Goetz, CG | 1 |
Gershanik, O; Luquin, MR; Obeso, JA; Scipioni, O; Vaamonde, J | 1 |
Heinz, A; Klewin, I; Klotz, P; Kuhn, W; Przuntek, H; Suchy, I | 1 |
Baronti, F; Brughitta, G; Chase, TN; Conant, KE; Davis, TL; Giuffra, M; Mouradian, MM | 1 |
Laihinen, A; Rinne, UK; Suchy, I | 1 |
Graff, E; Korczyn, AD; Rabey, JM; Shabtai, H; Vered, Y | 1 |
Antonozzi, I; Bonifati, V; Lestingi, L; Meco, G; Stocchi, F | 1 |
Madeja, UD | 1 |
Anderson, JJ; Bravi, D; Chase, TN; Dagani, F; Davis, TL; Ferrari, R; Gillespie, M | 1 |
Agnoli, A; Baronti, F; Horowski, R; Lucarelli, C; Ruggieri, S; Stocchi, F; Viselli, F | 1 |
Bhatt, MH; Calne, DB; Fleetham, JA; Keenan, SP | 1 |
Horowski, R; Runge, I | 1 |
Bruggi, P; Horowski, R; Martignoni, E; Nappi, G; Pacchetti, C; Rainer, E; Runge, I | 1 |
Ogawa, N | 1 |
Luquin, MR; Obeso, JA; Vaamonde, J | 2 |
Korczyn, AD; Rabey, JM; Streifler, M; Treves, T | 2 |
Genitrini, S; Giovannini, P; Girotti, F; Piccolo, I; Scigliano, G; Suchy, I; Testa, D | 1 |
Boyson, SJ | 1 |
Rinne, UK | 4 |
Luquín, MR; Martínez Lage, JM; Obeso, JA; Vaamonde, J | 2 |
Bono, G; Cavallini, A; Horowski, R; Martignoni, E; Micieli, G; Nappi, G; Rossi, F | 1 |
Agnoli, A; Agostini, C; Barbato, L; Bragoni, M; Carta, A; Ruggieri, S; Stocchi, F | 1 |
Attanasio, A; Cannata, D; Capria, A; Fioravanti, M; Quatrana, M; Ruggieri, S; Stocchi, F | 1 |
Luquin, MR; Martínez-Lage, JM; Obeso, JA | 1 |
Todes, CJ | 1 |
Coleman, R; Critchley, P; Grandas Perez, F; Marsden, CD; Parkes, D; Quinn, N | 1 |
Horowski, R | 1 |
Kito, S; Matsubayashi, H; Miyoshi, R; Mizuno, K; Nitta, K; Tahara, E; Yamamura, Y | 1 |
Kempster, PA; Lees, AJ; Stern, GM; Stibe, CM | 1 |
Baumann, G; Chin, L; Lieberman, A | 1 |
Critchley, PH; Grandas Perez, F; Marsden, CD; Parkes, JD; Quinn, NP | 1 |
Fernandez Pardal, M; Gatto, M; Micheli, F; Perez y Gonzalez, N | 1 |
García, S; Gershanik, OS; Scipioni, O | 1 |
Agnoli, A; Antonini, A; Baronti, F; Bellantuono, P; Bravi, D; Brughita, G; Ruggieri, S; Stocchi, F | 1 |
Horowski, R; Marsden, CD; Obeso, JA | 1 |
Aljanati, R; Caamaño, JL; Chouza, C; de Medina, O; Romero, S; Scaramelli, A | 1 |
Filip, V; Filipová, M; Kás, S; Krejcová, H; Krivka, J; Macek, Z; Marková, J; Müllerová, S; Votavová, M; Zizková, B | 1 |
Birkmayer, W | 1 |
Birkmayer, JD; Birkmayer, W | 1 |
Jellinger, K | 1 |
Agnoli, A; Antonini, A; Baronti, F; Bellantuono, P; Bravi, D; Brughitta, G; Ruggieri, S; Stocchi, F | 1 |
Bittkau, S; Przuntek, H | 1 |
Krause, W; Nieuweboer, B; Ruggieri, S; Stocchi, F; Suchy, I | 1 |
Agnoli, A; Bragoni, M; Bravi, D; Carta, A; Giorgi, L; Ruggieri, S; Stocchi, F | 1 |
Agnoli, A; Antonini, A; Bragoni, M; Carta, A; Ruggieri, SA; Stocchi, F | 1 |
Caraceni, T; Giovannini, P; Piccolo, I; Scigliano, G; Soliveri, P; Suchy, I | 2 |
Agnoli, A; Brughitta, G; Ruggieri, S; Stocchi, F | 1 |
Bracco, F; Ferla, S; Giometto, B; Meneghetti, G; Schergna, E | 1 |
Rinne, UK; Suchy, I; Wachtel, H | 1 |
Herbster, G; Koller, WC | 1 |
Attanasio, A; Cannata, D; Capria, A; Quatrana, M; Ruggieri, S; Stocchi, F | 1 |
Filipová, M; Karen, P; Kás, S; Krejcová, H; Macek, Z; Roth, B; Rozsíval, V; Votavová, M | 1 |
Chin, D; Huang, CY; Yu, YL | 1 |
Grandas, F; Luquin, MR; Martinez Lage, JM; Obeso, JA; Vaamonde, J | 1 |
Catarzi, L; Degl'Innocenti, F; Ginanneschi, A; Magnolfi, S; Marini, P | 1 |
Critchley, P; Parkes, D | 1 |
Dorow, R; Horowski, R; Luquin, MR; Martínez-Lage, JM; Nieuweboer, B; Obeso, JA; Parada, J; Tresguerres, J | 1 |
Brücke, T; Danielczyk, W; Riederer, P; Simányi, M; Sofic, E | 1 |
Fernández Pardal, M; Leiguarda, R; Micheli, F | 1 |
Goldstein, M; Lieberman, AN | 1 |
Luquin, MR; Martínez Lage, JM; Obeso, JA | 2 |
Agid, Y; Dubois, B | 1 |
Kapfhammer, HP; Rüther, E | 1 |
Goldstein, M; Gopinathan, G; Hiesiger, E; Leibowitz, M; Lieberman, AN; Nelson, J; Walker, R | 1 |
Alfonsi, E; Horowski, R; Martignoni, E; Nappi, G; Sandrini, G | 1 |
Bonuccelli, U; Corsini, GU; Del Zompo, M; Rainer, E | 1 |
18 review(s) available for lisuride and Idiopathic Parkinson Disease
Article | Year |
---|---|
Anti-Parkinson's disease drugs and pharmacogenetic considerations.
Topics: Aryl Hydrocarbon Hydroxylases; Benzothiazoles; Benztropine; Bromocriptine; Cabergoline; Catechols; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Ergolines; Genetic Markers; Humans; Indans; Indoles; Levodopa; Lisuride; Nitriles; Parkinson Disease; Pergolide; Pharmacogenetics; Pramipexole; Receptors, Dopamine D2; Receptors, Dopamine D3; Reproducibility of Results; Selegiline | 2013 |
Use of apomorphine in Parkinson's disease.
Topics: Antiparkinson Agents; Apomorphine; Dopamine; Dopamine Agonists; Humans; Levodopa; Lisuride; Parkinson Disease | 2008 |
DA agonists -- ergot derivatives: bromocriptine: management of Parkinson's disease.
Topics: Benzophenones; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Therapy, Combination; Enzyme Inhibitors; Ergolines; Ergot Alkaloids; Humans; Levodopa; Lisuride; Nitrophenols; Parkinson Disease; Pergolide; Randomized Controlled Trials as Topic; Tolcapone | 2002 |
DA agonists -- ergot derivatives: lisuride: management of Parkinson's disease.
Topics: Dopamine Agonists; Drug Therapy, Combination; Ergot Alkaloids; Humans; Levodopa; Lisuride; Parkinson Disease; Psychomotor Disorders; Randomized Controlled Trials as Topic | 2002 |
[Use of dopamine agonists in the treatment of Parkinson's disease].
Topics: Antiparkinson Agents; Benzothiazoles; Bromocriptine; Cabergoline; Controlled Clinical Trials as Topic; Dopamine Agonists; Ergolines; Humans; Indoles; Lisuride; Parkinson Disease; Pergolide; Piribedil; Placebos; Pramipexole; Serotonin Receptor Agonists; Thiazoles; Time Factors | 2002 |
Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004.
Topics: Amantadine; Antiparkinson Agents; Apomorphine; Benzophenones; Benzothiazoles; Bromocriptine; Cabergoline; Catechol O-Methyltransferase Inhibitors; Deep Brain Stimulation; Dihydroergocryptine; Ergolines; Fetal Tissue Transplantation; Globus Pallidus; Humans; Indans; Indoles; Levodopa; Lisuride; Mesencephalon; Monoamine Oxidase Inhibitors; Neurosurgical Procedures; Nitrophenols; Parkinson Disease; Pergolide; Piribedil; Pramipexole; Selegiline; Thiazoles; Tolcapone | 2005 |
[New directions in contemporary pharmacotherapy of parkinsonism (review)].
Topics: Adrenergic beta-Antagonists; Anti-Anxiety Agents; Antiparkinson Agents; Apomorphine; Aromatic Amino Acid Decarboxylase Inhibitors; Bromocriptine; Drug Therapy, Combination; gamma-Aminobutyric Acid; Humans; Levodopa; Lisuride; Oxprenolol; Parkinson Disease; Piracetam; Piribedil; Propranolol | 1984 |
The pharmacology of Parkinson's disease: basic aspects and recent advances.
Topics: Animals; Antiparkinson Agents; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Brain; Bromocriptine; Carbidopa; Corpus Striatum; Dopamine; Ergolines; Humans; Kidney; Kinetics; Levodopa; Lisuride; Liver; Methyldopa; Norepinephrine; Parkinson Disease; Pergolide; Receptors, Dopamine; Selegiline; Serotonin; Stereotyped Behavior; Substantia Nigra; Tyramine | 1984 |
Parkinson's disease: drug-induced psychiatric states.
Topics: Aged; Anxiety; Bipolar Disorder; Clozapine; Depression; Electroconvulsive Therapy; Humans; Levodopa; Lisuride; Male; Ondansetron; Parkinson Disease; Psychoses, Substance-Induced; Sexual Dysfunctions, Psychological | 1995 |
Treatment of Parkinson's disease should begin with a dopamine agonist.
Topics: Benzothiazoles; Bromocriptine; Cabergoline; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ergolines; Humans; Indoles; Levodopa; Lisuride; Parkinson Disease; Pergolide; Pramipexole; Receptors, Dopamine D2; Thiazoles | 1999 |
Lisuride versus bromocriptine for levodopa-induced complications in Parkinson's disease.
Topics: Antiparkinson Agents; Bromocriptine; Dyskinesia, Drug-Induced; Humans; Levodopa; Lisuride; Parkinson Disease | 2000 |
Lisuride for levodopa-induced complications in Parkinson's disease.
Topics: Antiparkinson Agents; Dyskinesia, Drug-Induced; Humans; Levodopa; Lisuride; Parkinson Disease | 2000 |
[Parkinson disease: diagnostic and therapeutic criteria].
Topics: Activities of Daily Living; Adult; Aged; Amantadine; Antiparkinson Agents; Bromocriptine; Diagnosis, Differential; Dopamine Agents; Dopamine Agonists; Female; Globus Pallidus; Humans; Indoles; Levodopa; Lewy Body Disease; Lisuride; Male; Mental Status Schedule; Neurosurgery; Parkinson Disease; Parkinsonian Disorders; Piribedil; Psychiatric Status Rating Scales; Serotonin Receptor Agonists; Stereotaxic Techniques; Supranuclear Palsy, Progressive; Surveys and Questionnaires; Thalamus | 2001 |
Dopaminergic agonists in the treatment of Parkinson's disease.
Topics: Apomorphine; Bromocriptine; Dopamine Agents; Humans; Lactose; Lisuride; Methylcellulose; Oxazines; Parkinson Disease; Pergolide; Receptors, Dopamine | 1992 |
[The dopamine agonist, lisuride, in the therapy of Parkinson disease].
Topics: Drug Therapy, Combination; Humans; Levodopa; Lisuride; Parkinson Disease; Selegiline | 1992 |
[New anti-parkinsonian drugs].
Topics: Antiparkinson Agents; Bromocriptine; Humans; Lisuride; Parkinson Disease; Pergolide; Picolinic Acids; Selegiline | 1991 |
Continuous dopaminergic stimulation: state of the art and outlook.
Topics: Antiparkinson Agents; Apomorphine; Dopamine; Drug Tolerance; Dyskinesia, Drug-Induced; Humans; Infusion Pumps; Lisuride; Mental Disorders; Movement; Neurology; Parkinson Disease; Stimulation, Chemical | 1988 |
Bromocriptine in Parkinson disease.
Topics: Aged; Animals; Bromocriptine; Drug Administration Schedule; Ergolines; Humans; Levodopa; Lisuride; Middle Aged; Parkinson Disease; Pergolide; Time Factors | 1985 |
28 trial(s) available for lisuride and Idiopathic Parkinson Disease
Article | Year |
---|---|
Prospective randomized trial of lisuride infusion versus oral levodopa in patients with Parkinson's disease.
Topics: Administration, Oral; Antiparkinson Agents; Dyskinesias; Home Infusion Therapy; Humans; Levodopa; Lisuride; Middle Aged; Parkinson Disease; Prospective Studies; Severity of Illness Index | 2002 |
Pergolide and lisuride for levodopa-induced oscillations.
Topics: Clinical Trials as Topic; Ergolines; Female; Humans; Lisuride; Male; Parkinson Disease; Pergolide | 1981 |
Therapeutic use of a selective cAMP phosphodiesterase inhibitor (Rolipram) in Parkinson's disease.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Aged; Humans; Lisuride; Middle Aged; Parkinson Disease; Pyrrolidinones; Receptors, Dopamine; Rolipram | 1983 |
Further studies with lisuride in Parkinson's disease.
Topics: Aged; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Ergolines; Female; Humans; Lisuride; Male; Middle Aged; Parkinson Disease | 1983 |
Lisuride treatment in Parkinson's disease: clinical and pharmacokinetic studies.
Topics: Bromocriptine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Ergolines; Female; Humans; Lisuride; Male; Middle Aged; Parkinson Disease | 1983 |
Assessment of hypokinesia in Parkinsonism.
Topics: Adult; Aged; Bromocriptine; Clinical Trials as Topic; Ergolines; Humans; Levodopa; Lisuride; Male; Middle Aged; Motor Activity; Movement; Parkinson Disease; Placebos; Posture; Time Factors | 1981 |
Lisuride in Parkinson disease: efficacy of lisuride compared to levodopa.
Topics: Aged; Clinical Trials as Topic; Double-Blind Method; Ergolines; Female; Humans; Levodopa; Lisuride; Male; Middle Aged; Parkinson Disease | 1981 |
Lisuride combined with levodopa in advanced Parkinson disease.
Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Ergolines; Humans; Levodopa; Lisuride; Middle Aged; Parkinson Disease | 1981 |
Lisuride versus bromocriptine treatment in Parkinson disease: a double-blind study.
Topics: Adult; Aged; Bromocriptine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Ergolines; Female; Humans; Lisuride; Male; Middle Aged; Parkinson Disease; Random Allocation | 1982 |
Apomorphine and lisuride infusion. A comparative chronic study.
Topics: Apomorphine; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Levodopa; Lisuride; Long-Term Care; Middle Aged; Movement Disorders; Neurologic Examination; Parkinson Disease | 1993 |
A study on the effect and tolerance of lisuride on Parkinson's disease.
Topics: Age of Onset; Aged; Antiparkinson Agents; Benserazide; Disease Progression; Drug Therapy, Combination; Female; Humans; Levodopa; Lisuride; Male; Middle Aged; Parkinson Disease; Prolactin; Psychiatric Status Rating Scales | 1996 |
Effects of terguride on anterior pituitary function in parkinsonian patients treated with L-dopa: a double-blind study versus placebo.
Topics: Aged; Antiparkinson Agents; Dopamine Agonists; Double-Blind Method; Female; Humans; Hyperprolactinemia; Levodopa; Lisuride; Male; Middle Aged; Parkinson Disease; Pituitary Function Tests; Pituitary Gland, Anterior; Pituitary Hormones, Anterior | 1996 |
Alpha-dihydroergocryptine in Parkinson's disease: a multicentre randomized double blind parallel group study.
Topics: Aged; Antiparkinson Agents; Dihydroergotoxine; Disabled Persons; Dopamine Agonists; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Levodopa; Lisuride; Male; Middle Aged; Movement Disorders; Parkinson Disease; Treatment Outcome | 1999 |
Five-year follow-up of early lisuride and levodopa combination therapy versus levodopa monotherapy in de novo Parkinson's disease. The French Lisuride Study Group.
Topics: Adult; Aged; Antiparkinson Agents; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Levodopa; Lisuride; Male; Middle Aged; Neurologic Examination; Parkinson Disease | 2000 |
Lisuride in Parkinson's disease.
Topics: Administration, Oral; Antiparkinson Agents; Bromocriptine; Clinical Trials as Topic; Drug Therapy, Combination; Ergolines; Humans; Lisuride; Parkinson Disease | 1979 |
Pergolide and lisuride for Parkinson's disease.
Topics: Antiparkinson Agents; Clinical Trials as Topic; Drug Synergism; Drug Therapy, Combination; Ergolines; Humans; Levodopa; Lisuride; Parkinson Disease | 1979 |
Comparison of lisuride and bromocriptine in the treatment of advanced Parkinson's disease.
Topics: Aged; Bromocriptine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Levodopa; Lisuride; Male; Middle Aged; Neurologic Examination; Parkinson Disease | 1992 |
TRH test and the continuous dopaminergic stimulation in complicated Parkinson's disease.
Topics: Antiparkinson Agents; Drug Therapy, Combination; Female; Humans; Infusion Pumps; Levodopa; Lisuride; Male; Motor Skills; Neurologic Examination; Parkinson Disease; Prolactin; Receptors, Dopamine; Thyrotropin; Thyrotropin-Releasing Hormone | 1992 |
Antagonist effect of terguride in Parkinson's disease.
Topics: Adult; Aged; Dopamine Agents; Humans; Levodopa; Lisuride; Middle Aged; Parkinson Disease | 1991 |
Lisuride plus selegiline in the treatment of early Parkinson's disease.
Topics: Adult; Aged; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Lisuride; Male; Middle Aged; Motor Skills; Neurologic Examination; Parkinson Disease; Selegiline | 1991 |
The beneficial effect of chronic lisuride administration compared with levodopa in Parkinson's disease.
Topics: Aged; Aged, 80 and over; Carbidopa; Female; Follow-Up Studies; Humans; Levodopa; Lisuride; Long-Term Care; Male; Middle Aged; Motor Skills; Neurologic Examination; Parkinson Disease | 1990 |
A study of the cardiopressor effects of lisuride in the treatment of parkinsonism and pathological aging brain.
Topics: Aged; Aging; Blood Pressure; Catecholamines; Circadian Rhythm; Clinical Trials as Topic; Cognition Disorders; Double-Blind Method; Ergolines; Female; Heart Rate; Humans; Lisuride; Male; Middle Aged; Parkinson Disease; Posture; Time Factors | 1989 |
Lisuride, a dopamine agonist in the treatment of early Parkinson's disease.
Topics: Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Lisuride; Male; Middle Aged; Parkinson Disease | 1989 |
A combined regimen of subcutaneous lisuride and oral Madopar HBS in Parkinson's disease.
Topics: Administration, Oral; Benserazide; Clinical Trials as Topic; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Drug Tolerance; Ergolines; Humans; Hydrazines; Infusion Pumps; Levodopa; Lisuride; Parkinson Disease; Severity of Illness Index | 1988 |
Terguride in parkinsonism. A multicenter trial.
Topics: Adult; Aged; Aged, 80 and over; Clinical Trials as Topic; Ergolines; Female; Humans; Lisuride; Male; Middle Aged; Motor Skills; Neurologic Examination; Parkinson Disease | 1988 |
Lisuride in de novo parkinsonian patients: a four-year follow-up.
Topics: Adult; Aged; Clinical Trials as Topic; Ergolines; Female; Follow-Up Studies; Humans; Lisuride; Male; Middle Aged; Parkinson Disease; Time Factors | 1988 |
Therapeutic effect of lisuride in advanced Parkinson's disease.
Topics: Aged; Clinical Trials as Topic; Ergolines; Female; Humans; Levodopa; Lisuride; Male; Middle Aged; Parkinson Disease; Time Factors | 1986 |
Evaluation of terguride in patients with Parkinson's disease.
Topics: Adult; Aged; Brain; Clinical Trials as Topic; Disability Evaluation; Ergolines; Female; Humans; Lisuride; Male; Middle Aged; Motor Skills; Parkinson Disease; Receptors, Dopamine | 1987 |
111 other study(ies) available for lisuride and Idiopathic Parkinson Disease
Article | Year |
---|---|
Designing lisuride intranasal nanocarrier system for reduction of oxidative damage with enhanced dopamine level in brain for Parkinsonism.
Topics: Animals; Antioxidants; Brain; Dopamine; Haloperidol; Lisuride; Oxidative Stress; Parkinson Disease; Rats | 2023 |
Transdermal lisuride delivery in the treatment of Parkinson's disease.
Topics: Administration, Cutaneous; Aged; Analysis of Variance; Drug Delivery Systems; Female; Humans; Linear Models; Lisuride; Male; Middle Aged; Parkinson Disease; Pilot Projects | 2004 |
Levodopa in the treatment of Parkinson's disease: current controversies.
Topics: Animals; Antiparkinson Agents; Apomorphine; Disease Models, Animal; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Haplorhini; Levodopa; Lisuride; Parkinson Disease; Pergolide | 2005 |
In vitro characterization of SLV308 (7-[4-methyl-1-piperazinyl]-2(3H)-benzoxazolone, monohydrochloride): a novel partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist.
Topics: Animals; Benzoxazoles; Binding, Competitive; Brain; CHO Cells; Colforsin; Cricetinae; Cyclic AMP; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Interactions; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Lisuride; Male; Molecular Structure; Parkinson Disease; Piperazines; Quinpirole; Radioligand Assay; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1A; Receptors, Dopamine D2; Receptors, Dopamine D3; Recombinant Fusion Proteins; Serotonin 5-HT1 Receptor Agonists; Serotonin Receptor Agonists | 2006 |
Striking differences of action of lisuride stereoisomers at histamine H1 receptors.
Topics: Animals; Antiparkinson Agents; Cell Membrane; Dopamine; Dopamine Agonists; GTP Phosphohydrolases; GTP-Binding Protein alpha Subunits, Gq-G11; Guinea Pigs; Humans; Ileum; Insecta; Lisuride; Male; Muscle Contraction; Parkinson Disease; Pyrilamine; Receptors, Histamine H1; RGS Proteins; Species Specificity; Stereoisomerism | 2006 |
Dopamine agonists and Parkinson's disease.
Topics: Antiparkinson Agents; Apomorphine; Brain; Bromocriptine; Ergolines; Ergot Alkaloids; Humans; Levodopa; Lisuride; Neurons; Parkinson Disease; Pergolide; Piribedil; Receptors, Dopamine | 1984 |
Dopamine agonists in Parkinson's disease.
Topics: Bromocriptine; Dopamine; Drug Therapy, Combination; Ergolines; Ergot Alkaloids; Humans; Levodopa; Lisuride; Parkinson Disease; Pergolide; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2 | 1984 |
Combination treatment with selective monoamine oxidase inhibitors and dopaminergic agonists in Parkinson's disease: biochemical and clinical observations.
Topics: Bromocriptine; Dopamine; Drug Therapy, Combination; Humans; Lisuride; Monoamine Oxidase Inhibitors; Parkinson Disease; Selegiline; Tranylcypromine | 1983 |
[Dopaminergic ergot combinations. A new therapeutic principle].
Topics: Bromocriptine; Dopamine Antagonists; Drug Combinations; Ergot Alkaloids; Female; Humans; Lisuride; Male; Parkinson Disease; Pituitary Neoplasms; Prolactin | 1983 |
Intravenous lisuride infusion for Parkinson's disease.
Topics: Ergolines; Humans; Infusions, Parenteral; Lisuride; Parkinson Disease | 1983 |
Pergolide and lisuride in advanced Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Ergolines; Humans; Lisuride; Middle Aged; Parkinson Disease; Pergolide; Retrospective Studies | 1984 |
Use of ergot derivative lisuride in Parkinson's disease.
Topics: Adult; Aged; Ergolines; Female; Humans; Hypotension; Lisuride; Male; Mental Disorders; Middle Aged; Nausea; Parkinson Disease; Sleep Wake Disorders; Vertigo; Vomiting | 1984 |
Bromocriptine and lisuride in Parkinson's disease.
Topics: Adult; Aged; Bromocriptine; Carboxy-Lyases; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Lisuride; Male; Middle Aged; Parkinson Disease | 1984 |
Lisuride in extrapyramidal disorders: a possible mechanism of action.
Topics: Animals; Basal Ganglia Diseases; Chorea; Corpus Striatum; Dystonia; Ergolines; Female; Humans; Lisuride; Male; Middle Aged; Parkinson Disease; Rats; Syndrome; Torticollis | 1984 |
Disposition of oral lisuride in Parkinson's disease.
Topics: Administration, Oral; Aged; Biological Availability; Ergolines; Female; Humans; Kinetics; Lisuride; Male; Middle Aged; Parkinson Disease; Radioimmunoassay | 1984 |
Bromocriptine and lisuride in Parkinson disease.
Topics: Aged; Bromocriptine; Carbidopa; Drug Therapy, Combination; Ergolines; Humans; Levodopa; Lisuride; Middle Aged; Parkinson Disease | 1983 |
[Effect of lisuride in the "on-off" phenomena due to L-dopa].
Topics: Aged; Antiparkinson Agents; Drug Evaluation; Drug Resistance; Ergolines; Female; Humans; Levodopa; Lisuride; Male; Middle Aged; Parkinson Disease | 1983 |
Lisuride and pergolide in Parkinson's disease.
Topics: Aged; Disability Evaluation; Dose-Response Relationship, Drug; Ergolines; Humans; Lisuride; Middle Aged; Parkinson Disease; Pergolide; Sleep | 1983 |
Bromocriptine--lisuride cross tolerance.
Topics: Aged; Bromocriptine; Drug Tolerance; Ergolines; Humans; Lisuride; Male; Middle Aged; Parkinson Disease | 1983 |
Lisuride in the treatment of parkinsonism.
Topics: Administration, Oral; Aged; Dose-Response Relationship, Drug; Ergolines; Female; Humans; Injections, Intravenous; Lisuride; Male; Middle Aged; Parkinson Disease; Receptors, Dopamine | 1983 |
Use of lisuride in advanced Parkinson's disease. Potent dopamine and serotonin agonist.
Topics: Aged; Ergolines; Female; Humans; Levodopa; Lisuride; Male; Middle Aged; Parkinson Disease; Psychoses, Substance-Induced | 1981 |
The use of lisuride, a potent dopamine and serotonin agonist, in the treatment of progressive supranuclear palsy.
Topics: Aged; Bulbar Palsy, Progressive; Ergolines; Female; Humans; Lisuride; Male; Middle Aged; Parkinson Disease | 1982 |
Lisuride in parkinsonism.
Topics: Adult; Aged; Bromocriptine; Double-Blind Method; Ergolines; Humans; Lisuride; Middle Aged; Movement; Parkinson Disease; Placebos; Reaction Time; Receptors, Serotonin; Sleep | 1981 |
Lisuride in parkinsonism.
Topics: Administration, Oral; Aged; Benzimidazoles; Chorea; Domperidone; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Ergolines; Female; Growth Hormone; Humans; Injections, Intravenous; Lisuride; Male; Middle Aged; Paralysis; Parkinson Disease; Parkinson Disease, Postencephalitic; Parkinson Disease, Secondary; Piperidines; Prolactin | 1981 |
Parkinson's disease: new drugs help but no cure on the horizon.
Topics: Antiparkinson Agents; Ergolines; Humans; Lisuride; Parkinson Disease; Pergolide | 1981 |
Growth hormone and prolactin stimulation by Madopar in Parkinson's disease.
Topics: Adult; Aged; Antiparkinson Agents; Benserazide; Drug Combinations; Female; Growth Hormone; Humans; Hydrazines; Levodopa; Lisuride; Male; Middle Aged; Parkinson Disease; Prolactin; Receptors, Dopamine | 1981 |
The role of D-1 and D-2 receptors.
Topics: Adenylyl Cyclases; Bromocriptine; Growth Hormone; Humans; Levodopa; Lisuride; Metoclopramide; Parkinson Disease; Pimozide; Prolactin; Receptors, Dopamine | 1980 |
Lisuride in the treatment of Parkinsonism.
Topics: Administration, Oral; Aged; Bromocriptine; Drug Therapy, Combination; Ergolines; Humans; Injections, Intravenous; Levodopa; Lisuride; Middle Aged; Parkinson Disease | 1980 |
[Clinical aspects and follow-up of dopamine-induced psychoses in continuous dopaminergic therapy and their implications for the dopamine hypothesis of schizophrenic symptoms].
Topics: Aged; Brain; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Infusion Pumps; Levodopa; Lisuride; Male; Middle Aged; Neurologic Examination; Neuropsychological Tests; Parkinson Disease; Psychoses, Substance-Induced; Schizophrenia; Schizophrenic Psychology; Synaptic Transmission | 1995 |
[Brain SPECT with 123I-lisuride in patients with Parkinson's disease and controls].
Topics: Adult; Aged; Binding, Competitive; Brain; Case-Control Studies; Female; Humans; Iodine Radioisotopes; Lisuride; Male; Middle Aged; Parkinson Disease; Receptors, Dopamine D2; Reference Values; Tomography, Emission-Computed, Single-Photon | 1995 |
Combination treatment of the partial D2 agonist terguride with the D1 agonist SKF 82958 in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned parkinsonian cynomolgus monkeys.
Topics: Animals; Benzazepines; Dopamine Agonists; Drug Therapy, Combination; Lisuride; Macaca fascicularis; MPTP Poisoning; Parkinson Disease; Receptors, Dopamine D1; Receptors, Dopamine D2 | 1995 |
Intrastriatal infusion of lisuride--a potential treatment for Parkinson's disease? Behavioral and autoradiographic studies in 6-OHDA lesioned rats.
Topics: Animals; Autoradiography; Corpus Striatum; Infusions, Parenteral; Lisuride; Male; Motor Activity; Oxidopamine; Parkinson Disease; Radioligand Assay; Rats; Rotation | 1994 |
Terguride in fluctuating parkinsonian patients: a double-blind study versus placebo.
Topics: Adult; Aged; Dopamine; Dopamine Agents; Double-Blind Method; Drug Therapy, Combination; Drug Tolerance; Female; Humans; Levodopa; Lisuride; Male; Middle Aged; Parkinson Disease; Placebos | 1993 |
[11C]raclopride and positron emission tomography in previously untreated patients with Parkinson's disease: Influence of L-dopa and lisuride therapy on striatal dopamine D2-receptors.
Topics: Adult; Aged; Animals; Carbon Radioisotopes; Corpus Striatum; Dopamine D2 Receptor Antagonists; Female; Humans; Levodopa; Lisuride; Macaca mulatta; Male; Middle Aged; Parkinson Disease; Raclopride; Receptors, Dopamine D2; Salicylamides; Tomography, Emission-Computed | 1994 |
Terguride for dyskinesias.
Topics: Dopamine Agents; Humans; Levodopa; Lisuride; Parkinson Disease | 1993 |
[Is dopaminergic therapy immunologically rejuvinating? Increased interferon-gamma production with the dopaminergic agent lisuride].
Topics: Adult; Aged; Dose-Response Relationship, Drug; Female; Humans; Infusion Pumps; Interferon-gamma; Lisuride; Male; Middle Aged; Parkinson Disease | 1994 |
Combination therapy for PD.
Topics: Antiparkinson Agents; Bromocriptine; Drug Therapy, Combination; Humans; Levodopa; Lisuride; Parkinson Disease; Randomized Controlled Trials as Topic | 1993 |
Slowing of information processing in Parkinson's disease.
Topics: Aged; Cerebral Cortex; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Levodopa; Lisuride; Male; Mental Processes; Middle Aged; Neuropsychological Tests; Parkinson Disease; Problem Solving; Reaction Time; Selegiline; Thinking | 1993 |
Iodine-123-iodo-lisuride SPECT in Parkinson's disease.
Topics: Adult; Aged; Brain; Case-Control Studies; Corpus Striatum; Female; Humans; Iodine Radioisotopes; Lisuride; Male; Middle Aged; Parkinson Disease; Receptors, Dopamine D2; Time Factors; Tomography, Emission-Computed, Single-Photon | 1996 |
[Parkinson disease--problems in long-term treatment. Dopamine agonists optimize L-dopa therapy].
Topics: Antiparkinson Agents; Dopamine Agonists; Drug Therapy, Combination; Humans; Levodopa; Lisuride; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Substance Withdrawal Syndrome | 1997 |
[Parkinson disease. Early diagnosis and combined therapy improve prognosis. Report from the Symposium: "New and successful attempts at the diagnosis and therapy of Parkinson disease"].
Topics: Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Levodopa; Lisuride; Parkinson Disease; Prognosis | 1993 |
Clinical implications of sustained dopaminergic stimulation.
Topics: Aged; Benserazide; Carbidopa; Delayed-Action Preparations; Dopamine Agonists; Drug Combinations; Dyskinesia, Drug-Induced; Follow-Up Studies; Humans; Levodopa; Lisuride; Parkinson Disease; Reaction Time | 1994 |
2-[123I]-iodolisuride SPET visualizes dopaminergic loss in de-novo parkinsonian patients: is it a marker of striatal pre-synaptic degeneration?
Topics: Aged; Brain; Cerebellum; Corpus Striatum; Dopamine; Female; Functional Laterality; Humans; Iodine Radioisotopes; Lisuride; Male; Middle Aged; Nerve Degeneration; Organ Specificity; Parkinson Disease; Regression Analysis; Synapses; Tissue Distribution; Tomography, Emission-Computed, Single-Photon | 1997 |
Efficacy of a low-dose subcutaneous lisuride infusion in Parkinson's disease.
Topics: Administration, Oral; Adult; Antiparkinson Agents; Dopamine Agonists; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infusions, Parenteral; Levodopa; Lisuride; Male; Middle Aged; Motor Activity; Parkinson Disease; Severity of Illness Index; Skin; Treatment Outcome | 1998 |
[Dermal application of lisuride on parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the common marmoset and on cases with Parkinson's disease].
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Administration, Cutaneous; Aged; Animals; Antiparkinson Agents; Callithrix; Circadian Rhythm; Disease Models, Animal; Dopamine Agonists; Female; Humans; Lisuride; Male; Middle Aged; Motor Activity; Parkinson Disease; Parkinson Disease, Secondary; Time Factors; Treatment Outcome | 1998 |
Effects of the method of drawing regions of interest on the differential diagnosis of extrapyramidal syndromes using 123I-iodolisuride SPET.
Topics: Adult; Aged; Basal Ganglia Diseases; Brain; Brain Chemistry; Caudate Nucleus; Corpus Striatum; Cysteine; Female; Frontal Lobe; Humans; Iodine Radioisotopes; Lisuride; Male; Occipital Lobe; Organotechnetium Compounds; Parkinson Disease; Perfusion; Radiopharmaceuticals; Receptors, Dopamine D2; Tomography, Emission-Computed, Single-Photon | 1999 |
Ropinirole: new preparation. Wait for more convincing data.
Topics: Antiparkinson Agents; Bromocriptine; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; France; Humans; Indoles; Levodopa; Lisuride; Parkinson Disease; Time Factors; Treatment Outcome | 1998 |
Sleep attacks and Parkinson's disease treatment.
Topics: Accidents, Traffic; Aged; Antiparkinson Agents; Bromocriptine; Dopamine Agonists; Female; Humans; Lisuride; Male; Middle Aged; Narcolepsy; Parkinson Disease; Pergolide; Piribedil | 2000 |
Long-duration effect and the postsynaptic compartment: study using a dopamine agonist with a short half-life.
Topics: Adult; Dopamine Agonists; Double-Blind Method; Excitatory Postsynaptic Potentials; Female; Half-Life; Humans; Lisuride; Male; Middle Aged; Parkinson Disease; Time | 2001 |
Efficacy and tolerability of dopamine agonists in a parkinsonian population.
Topics: Age of Onset; Aged; Aging; Benzothiazoles; Bromocriptine; Dopamine Agonists; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Drug Tolerance; Ergolines; Female; Follow-Up Studies; Humans; Indoles; Levodopa; Lisuride; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Retrospective Studies; Thiazoles; Treatment Outcome | 2001 |
Quantitative analysis of striatal dopamine D2 receptors with 123 I-iodolisuride SPECT in degenerative extrapyramidal diseases.
Topics: Aged; Aged, 80 and over; Basal Ganglia Diseases; Corpus Striatum; Diagnosis, Differential; False Positive Reactions; Female; Humans; Iodine Radioisotopes; Lisuride; Male; Middle Aged; Multiple System Atrophy; Neurodegenerative Diseases; Parkinson Disease; Parkinsonian Disorders; Receptors, Dopamine D2; Supranuclear Palsy, Progressive; Tomography, Emission-Computed, Single-Photon | 2001 |
Poetic talent unmasked by treatment of Parkinson's disease.
Topics: Antiparkinson Agents; Creativity; Dopamine Agonists; Humans; Levodopa; Libido; Lisuride; Male; Middle Aged; Parkinson Disease; Poetry as Topic; Serotonin Receptor Agonists | 2001 |
Levodopa-induced dyskinesias in Parkinson's disease: clinical and pharmacological classification.
Topics: Aged; Apomorphine; Chlorpromazine; Dopamine Agents; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Electromyography; Female; Humans; Levodopa; Lisuride; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Parkinson Disease, Secondary; Receptors, Dopamine; Sulpiride | 1992 |
Long-term observation of chronic subcutaneous administration of lisuride in the treatment of motor fluctuations in Parkinson's disease.
Topics: Aged; Dyskinesia, Drug-Induced; Female; Humans; Injections, Subcutaneous; Levodopa; Lisuride; Male; Middle Aged; Parkinson Disease; Psychomotor Performance | 1992 |
Continuous lisuride effects on central dopaminergic mechanisms in Parkinson's disease.
Topics: Adult; Analysis of Variance; Drug Therapy, Combination; Humans; Levodopa; Lisuride; Middle Aged; Movement; Parkinson Disease; Receptors, Dopamine | 1992 |
Improvement of parkinsonian features correlate with high plasma levodopa values after broad bean (Vicia faba) consumption.
Topics: Aged; Bromocriptine; Carbidopa; Combined Modality Therapy; Fabaceae; Female; Humans; Levodopa; Lisuride; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Plants, Medicinal | 1992 |
Effect of aging and dopaminomimetic therapy on mitochondrial respiratory function in Parkinson's disease.
Topics: Age Factors; Blood Glucose; Blood Platelets; Carbidopa; Drug Therapy, Combination; Energy Metabolism; Female; Humans; Lactates; Lactic Acid; Levodopa; Lisuride; Male; Middle Aged; Mitochondria; Oxygen Consumption; Parkinson Disease; Receptors, Dopamine; Selegiline | 1992 |
Pleuropulmonary disease associated with dopamine agonist therapy.
Topics: Aged; Cabergoline; Dopamine Agents; Ergolines; Female; Humans; Lisuride; Lung Diseases; Male; Middle Aged; Parkinson Disease; Pleural Diseases; Radiography | 1991 |
Can we differentiate symptomatic and neuroprotective effects in parkinsonism? The dopamine agonist lisuride delays the need for levodopa therapy to a similar extent as reported for deprenyl.
Topics: Humans; Levodopa; Lisuride; Nervous System; Parkinson Disease; Selegiline; Survival Analysis | 1991 |
Subcutaneous lisuride infusion in Parkinson's disease. Response to chronic administration in 34 patients.
Topics: Adult; Aged; Aromatic Amino Acid Decarboxylase Inhibitors; Drug Combinations; Female; Humans; Levodopa; Lisuride; Male; Middle Aged; Parkinson Disease | 1991 |
Terguride in the treatment of Parkinson disease: preliminary experience.
Topics: Dyskinesia, Drug-Induced; Humans; Levodopa; Lisuride; Male; Middle Aged; Parkinson Disease | 1990 |
Treatment of Parkinson's disease.
Topics: Antiparkinson Agents; Carbidopa; Drug Combinations; Drug Therapy, Combination; Ergolines; Humans; Levodopa; Lisuride; Parkinson Disease | 1990 |
Dopaminergic responsiveness to apomorphine after chronic treatment with subcutaneous lisuride infusion in Parkinson's disease.
Topics: Administration, Oral; Adult; Aged; Apomorphine; Drug Tolerance; Ergolines; Humans; Infusion Pumps; Levodopa; Lisuride; Middle Aged; Movement Disorders; Parkinson Disease | 1990 |
Combination of a dopamine agonist, MAO-B inhibitor and levodopa--a new strategy in the treatment of early Parkinson's disease.
Topics: Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Lisuride; Male; Middle Aged; Parkinson Disease; Phenethylamines; Selegiline | 1989 |
Early dopamine agonist therapy in Parkinson's disease.
Topics: Antiparkinson Agents; Brain; Bromocriptine; Dopamine Agents; Drug Therapy, Combination; Humans; Levodopa; Lisuride; Parkinson Disease; Pergolide; Receptors, Dopamine | 1989 |
[Orally administered lisuride in the treatment of complex fluctuations of motion in Parkinson disease].
Topics: Administration, Oral; Adult; Aged; Drug Administration Schedule; Drug Evaluation; Ergolines; Female; Humans; Lisuride; Male; Middle Aged; Movement Disorders; Parkinson Disease | 1989 |
One year treatment with lisuride delivery pump in Parkinson's disease.
Topics: Adult; Drug Therapy, Combination; Ergolines; Female; Humans; Infusion Pumps; Levodopa; Lisuride; Male; Middle Aged; Parkinson Disease | 1989 |
Cardiovascular effects of lisuride continuous intravenous infusion in fluctuating Parkinson's disease.
Topics: Adult; Blood Pressure; Domperidone; Drug Therapy, Combination; Electrocardiography; Ergolines; Female; Heart Rate; Hemodynamics; Humans; Infusions, Intravenous; Lisuride; Male; Middle Aged; Parkinson Disease | 1989 |
Lisuride infusion pump: a device for the treatment of motor fluctuations in Parkinson's disease.
Topics: Ergolines; Female; Humans; Infusions, Parenteral; Injections, Subcutaneous; Lisuride; Male; Motor Activity; Movement Disorders; Parkinson Disease; Time Factors | 1986 |
Lisuride infusion pump for Parkinson's disease.
Topics: Adult; Aged; Ergolines; Humans; Infusions, Parenteral; Lisuride; Male; Middle Aged; Parkinson Disease | 1986 |
At the receiving end of the lisuride pump.
Topics: Drug Administration Schedule; Drug Implants; Ergolines; Humans; Injections, Subcutaneous; Lisuride; Parkinson Disease | 1986 |
Lisuride infusion pump for Parkinson's disease.
Topics: Adult; Dose-Response Relationship, Drug; Drug Evaluation; Drug Therapy, Combination; Ergolines; Female; Humans; Infusions, Parenteral; Levodopa; Lisuride; Male; Middle Aged; Parkinson Disease | 1986 |
Psychosis and the lisuride pump.
Topics: Drug Therapy, Combination; Ergolines; Humans; Infusions, Parenteral; Levodopa; Lisuride; Parkinson Disease; Psychoses, Substance-Induced | 1986 |
Psychiatric side-effects of high-dose lisuride therapy in parkinsonism.
Topics: Ergolines; Hallucinations; Humans; Lisuride; Paranoid Disorders; Parkinson Disease | 1986 |
Autoradiographic distributions of neurotransmitter receptors in the human brains of Parkinson's disease and primate models of MPTP-induced parkinsonism.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Autoradiography; Brain; Humans; Lisuride; Macaca; Neurotransmitter Agents; Parkinson Disease; Parkinson Disease, Secondary; Pyridines; Quinuclidinyl Benzilate; Receptors, Cholinergic; Receptors, Dopamine; Receptors, Neurotransmitter | 1987 |
Subcutaneous apomorphine in parkinsonian on-off oscillations.
Topics: Adult; Aged; Apomorphine; Domperidone; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Infusion Pumps; Injections, Subcutaneous; Levodopa; Lisuride; Male; Middle Aged; Parkinson Disease | 1988 |
MK 458, a selective and potent D2 receptor agonist in advanced Parkinson's disease.
Topics: Adult; Aged; Antiparkinson Agents; Carbidopa; Dopamine Agents; Female; Humans; Hypromellose Derivatives; Lactose; Levodopa; Lisuride; Methylcellulose; Middle Aged; Nausea; Oxazines; Parkinson Disease; Pergolide; Psychomotor Performance; Receptors, Dopamine | 1988 |
Subcutaneous administration of lisuride in the treatment of complex motor fluctuations in Parkinson's disease.
Topics: Drug Eruptions; Dyskinesia, Drug-Induced; Equipment Failure; Ergolines; Female; Humans; Infusion Pumps; Injections, Subcutaneous; Lisuride; Male; Mental Disorders; Movement; Movement Disorders; Parkinson Disease; Platelet Aggregation | 1988 |
Continuous subcutaneous lisuride infusions in Parkinson's disease.
Topics: Adult; Aged; Drug Eruptions; Dyskinesia, Drug-Induced; Ergolines; Female; Humans; Hypotension; Infusion Pumps; Lisuride; Male; Mental Disorders; Middle Aged; Movement; Parkinson Disease | 1988 |
Treatment of Parkinson's disease with subcutaneous lisuride infusions.
Topics: Aged; Drug Eruptions; Drug Therapy, Combination; Ergolines; Female; Hematoma; Humans; Infusion Pumps; Levodopa; Lisuride; Male; Mental Disorders; Middle Aged; Movement Disorders; Parkinson Disease | 1988 |
Lisuride infusion pump in Parkinson's disease. A report of two cases.
Topics: Aged; Drug Administration Schedule; Drug Eruptions; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Ergolines; Humans; Levodopa; Lisuride; Mental Disorders; Parkinson Disease | 1988 |
[On-off phenomena in Parkinson's disease. Continuous dopaminergic stimulation].
Topics: Aged; Chronic Disease; Drug Evaluation; Female; Humans; Levodopa; Lisuride; Male; Middle Aged; Parkinson Disease; Psychomotor Performance; Receptors, Dopamine | 1987 |
[Therapeutic strategies and tactics in parkinsonism].
Topics: Amantadine; Antidepressive Agents; Antiparkinson Agents; Benserazide; Carbidopa; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Humans; Levodopa; Lisuride; Motor Skills; Parkinson Disease; Selegiline; Sleep Initiation and Maintenance Disorders | 1986 |
Current and future approaches to therapy.
Topics: Antiparkinson Agents; Benserazide; Bromocriptine; Carbidopa; Drug Therapy, Combination; Humans; Levodopa; Lisuride; Parkinson Disease; Selegiline | 1987 |
Dopamine agonists as primary treatment in Parkinson's disease.
Topics: Antiparkinson Agents; Bromocriptine; Disability Evaluation; Drug Therapy, Combination; Ergolines; Humans; Levodopa; Lisuride; Long-Term Care; Parkinson Disease; Pergolide; Receptors, Dopamine | 1987 |
[Lisuride in the combination treatment of Parkinson disease].
Topics: Adult; Aged; Aged, 80 and over; Carboxy-Lyases; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Lisuride; Long-Term Care; Male; Middle Aged; Parkinson Disease | 1987 |
Subcutaneous lisuride infusion in Parkinson's disease: clinical results using different modes of administration.
Topics: Administration, Oral; Adult; Drug Therapy, Combination; Ergolines; Female; Humans; Infusion Pumps; Levodopa; Lisuride; Male; Middle Aged; Parkinson Disease; Time Factors | 1988 |
Chronic s.c. lisuride in Parkinson's disease--motor-performance and avoidance of psychiatric side effects.
Topics: Aged; Dose-Response Relationship, Drug; Ergolines; Female; Humans; Infusion Pumps; Lisuride; Male; Mental Disorders; Middle Aged; Movement; Parkinson Disease | 1988 |
Pharmacokinetics of lisuride after subcutaneous infusion.
Topics: Administration, Oral; Biological Availability; Ergolines; Humans; Infusion Pumps; Infusions, Parenteral; Injections, Intramuscular; Injections, Intravenous; Lisuride; Parkinson Disease; Time Factors | 1988 |
Comparison between L-dopa and lisuride intravenous infusions: a clinical study.
Topics: Adult; Drug Administration Schedule; Ergolines; Female; Humans; Infusions, Intravenous; Levodopa; Lisuride; Male; Middle Aged; Motor Skills; Parkinson Disease | 1988 |
Continuous dopaminergic stimulation in the management of complicated Parkinson's disease.
Topics: Adult; Ergolines; Female; Humans; Infusions, Intravenous; Levodopa; Lisuride; Male; Middle Aged; Parkinson Disease | 1988 |
Lisuride in Parkinson's disease. 4-year follow-up.
Topics: Adult; Aged; Ergolines; Female; Follow-Up Studies; Humans; Levodopa; Lisuride; Male; Middle Aged; Parkinson Disease; Time Factors | 1988 |
Problems in daily motor performances in Parkinson's disease: the continuous dopaminergic stimulation.
Topics: Administration, Oral; Adult; Aged; Carbidopa; Domperidone; Ergolines; Female; Humans; Infusions, Intravenous; Levodopa; Lisuride; Male; Middle Aged; Movement Disorders; Parkinson Disease | 1986 |
Terguride, a mixed dopamine agonist-antagonist, in animal models of Parkinson's disease.
Topics: Amphetamine; Animals; Apomorphine; Behavior, Animal; Brain; Disease Models, Animal; Ergolines; Levodopa; Lisuride; Male; Motor Activity; Parkinson Disease; Rats; Rats, Inbred Strains; Receptors, Dopamine; Stereotyped Behavior | 1987 |
Unusual cardiovascular response to intravenous lisuride bolus. Possible drug-induced coronary angiospasm.
Topics: Coronary Vasospasm; Electrocardiography; Ergolines; Humans; Injections, Intravenous; Lisuride; Male; Middle Aged; Parkinson Disease | 1987 |
[Lisuride in the treatment of Parkinson syndrome].
Topics: Aged; Ergolines; Humans; Lisuride; Male; Middle Aged; Parkinson Disease | 1987 |
The use of lisuride in severe Parkinson's disease.
Topics: Adult; Ergolines; Female; Humans; Lisuride; Male; Middle Aged; Parkinson Disease | 1986 |
Continuous dopaminergic stimulation in Parkinson's disease.
Topics: Antiparkinson Agents; Apomorphine; Dopamine; Humans; Levodopa; Lisuride; Parkinson Disease | 1987 |
Low dose lisuride in advanced Parkinson disease.
Topics: Adult; Aged; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ergolines; Follow-Up Studies; Humans; Levodopa; Lisuride; Middle Aged; Parkinson Disease | 1987 |
Transdihydrolisuride in parkinsonism.
Topics: Aged; Blood Pressure; Ergolines; Female; Humans; Levodopa; Lisuride; Male; Middle Aged; Movement Disorders; Nausea; Parkinson Disease; Psychoses, Substance-Induced | 1987 |
Parenteral administration of lisuride in Parkinson's disease.
Topics: Adult; Aged; Ergolines; Female; Humans; Infusion Pumps; Infusions, Intravenous; Lisuride; Male; Middle Aged; Motor Skills; Parkinson Disease | 1987 |
Comparison of efficacy of lisuride hydrogen maleate with increased doses of levodopa in parkinsonian patients.
Topics: Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Ergolines; Female; Humans; Levodopa; Lisuride; Male; Middle Aged; Motor Skills; Parkinson Disease | 1987 |
Terguride: partial dopamine agonist in the treatment of Parkinson's disease.
Topics: Aged; Aged, 80 and over; Ergolines; Female; Humans; Lisuride; Male; Motor Skills; Parkinson Disease | 1987 |
[Lisuride in Parkinson disease].
Topics: Adult; Aged; Drug Evaluation; Ergolines; Female; Humans; Lisuride; Male; Middle Aged; Parkinson Disease; Time Factors | 1985 |
Intravenous lisuride corrects oscillations of motor performance in Parkinson's disease.
Topics: Adult; Aged; Domperidone; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Ergolines; Female; Humans; Injections, Intravenous; Levodopa; Lisuride; Male; Middle Aged; Parkinson Disease | 1986 |
[Dopaminergic agonists in Parkinson disease].
Topics: Aged; Bromocriptine; Dopamine; Ergolines; Humans; Levodopa; Lisuride; Parkinson Disease; Pergolide; Piribedil | 1986 |
[Dopamine agonists in the therapy of parkinson syndrome].
Topics: Animals; Antiparkinson Agents; Binding, Competitive; Bromocriptine; Corpus Striatum; Dopamine; Humans; Levodopa; Lisuride; Neural Pathways; Parkinson Disease; Piribedil; Receptors, Dopamine; Substantia Nigra | 1985 |
The use of pergolide and lisuride, two experimental dopamine agonists, in patients with advanced Parkinson disease.
Topics: Adult; Aged; Alanine Transaminase; Antiparkinson Agents; Aspartate Aminotransferases; Cognition Disorders; Dopamine; Drug Evaluation; Ergolines; Female; Humans; Lisuride; Male; Middle Aged; Nausea; Neurologic Examination; Parkinson Disease; Pergolide; Vasculitis | 1985 |
Effects of lisuride on blink reflex habituation in Parkinson disease.
Topics: Adult; Aged; Amantadine; Blinking; Electrophysiology; Ergolines; Habituation, Psychophysiologic; Humans; Levodopa; Lisuride; Male; Middle Aged; Parkinson Disease | 1985 |
[Oral lisuride in Parkinson's disease].
Topics: Adult; Aged; Bromocriptine; Drug Evaluation; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Ergolines; Female; Humans; Levodopa; Lisuride; Male; Middle Aged; Parkinson Disease | 1985 |
Therapeutic efficacy of a partial dopamine agonist in drug-free parkinsonian patients.
Topics: Aged; Disability Evaluation; Dopamine; Drug Evaluation; Ergolines; Female; Humans; Lisuride; Male; Middle Aged; Nervous System; Parkinson Disease | 1985 |